{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:35:07Z","timestamp":1790606107087,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81625014"],"award-info":[{"award-number":["81625014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The Xpert MTB\/RIF assay is an automated molecular test that is designed to simultaneously detect <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (MTB) complex and rifampin resistance. However, there are relatively few studies on this method in China. Xpert has been routinely used at Peking University People\u2019s Hospital (PKUPH) since November 2016. Thus, the aim of this study was to evaluate the performance of Xpert, and provide a reference and guidance for the detection and diagnosis of TB in non-TB specialized hospitals.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The medical records of inpatients simultaneously tested with Xpert, acid-fast bacilli (AFB) smear microscopy, and interferon-gamma release assay (IGRA, by T-SPOT\u00ae.TB) at PKUPH from November 2016 to October 2018 were reviewed. Active TB cases were considered according to a composite reference standard (CRS). Then, the three methods were evaluated and compared.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 787 patients simultaneously tested with Xpert, AFB, and IGRA were enrolled; among them 11.3% (89\/787) were diagnosed and confirmed active pulmonary TB (PTB, 52 cases), extrapulmonary TB (EPTB, 17 cases), and tuberculous pleurisy (TP, 20 cases). The sensitivity of Xpert in detecting PTB, EPTB, and TP was 88.5, 76.5, and 15.0%, respectively, which was slightly lower than IGRA (96.2, 82.4, and 95.0%, respectively), but higher than AFB (36.5, 11.8, and 0%, respectively); IGRA showed the highest sensitivity, but its specificity (55.9, 67.1, and 45.2%, respectively) was significantly lower than Xpert (99.6, 99.4, and 100%, respectively) and AFB (99.0, 99.4, and 100%, respectively) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The sensitivity of Xpert in detecting lung tissue, cerebrospinal fluid, lymph nodes, and joint fluid was 100%, followed by sputum (88.5%), alveolar lavage (85.7%), and bronchoscopy secretion (81.2%); the pleural fluid sensitivity was the lowest, only 15.0%. For AFB negative patients, the sensitivity of Xpert in detecting PTB, EPTB, and TP was 84.9, 73.3, and 15.0%, respectively.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Xpert showed both high sensitivity and high specificity, and suggested its high value in TB diagnosis; however, the application of pleural fluid is still limited, and should be improved. Owing to the high sensitivity of IGRA, it is recommended for use as a supplementary test, especially for assisting in the diagnosis of TP and EPTB.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05004-8","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T08:02:32Z","timestamp":1590307352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A retrospective study on Xpert MTB\/RIF for detection of tuberculosis in a teaching hospital in China"],"prefix":"10.1186","volume":"20","author":[{"given":"Shuguang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"9","key":"5004_CR1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3201\/eid1209.050553","volume":"12","author":"LA te Beek","year":"2006","unstructured":"te Beek LA, van der Werf MJ, Richter C, Borgdorff MW. Extrapulmonary tuberculosis by nationality, the Netherlands, 1993-2001. Emerg Infect Dis. 2006;12(9):1375\u201382.","journal-title":"Emerg Infect Dis"},{"key":"5004_CR2","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Global tuberculosis report 2019. Available: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed 6 March 2020."},{"issue":"4","key":"5004_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S2213-2600(18)30057-2","volume":"6","author":"K Floyd","year":"2018","unstructured":"Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the end TB era. Lancet Respir Med. 2018;6(4):299\u2013314.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"5004_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1086\/605559","volume":"49","author":"HM Peto","year":"2009","unstructured":"Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009;49(9):1350\u20137.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"5004_CR5","doi-asserted-by":"crossref","first-page":"pii: 20431","DOI":"10.2807\/ese.18.12.20431-en","volume":"18","author":"A Sandgren","year":"2013","unstructured":"Sandgren A, Hollo V, van der Werf MJ. Extrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011. Euro Surveill. 2013;18(12):pii: 20431.","journal-title":"Euro Surveill"},{"issue":"3","key":"5004_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3201\/eid2503.180572","volume":"25","author":"Y Pang","year":"2019","unstructured":"Pang Y, An J, Shu W, Huo F, Chu N, Gao M, Qin S, Huang H, Chen X, Xu S. Epidemiology of Extrapulmonary tuberculosis among inpatients, China, 2008-2017. Emerg Infect Dis. 2019;25(3):457\u201364.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"5004_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.chest.2018.08.1035","volume":"155","author":"H Deshwal","year":"2019","unstructured":"Deshwal H, Avasarala SK, Ghosh S, Mehta AC. Forbearance with bronchoscopy: a review of gratuitous indications. Chest. 2019;155(4):834\u201347.","journal-title":"Chest."},{"issue":"1","key":"5004_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1473-3099(17)30474-7","volume":"18","author":"NC Bahr","year":"2018","unstructured":"Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, Bridge SC, Bangdiwala AS, Meya DB, Denkinger CM, et al. Diagnostic accuracy of Xpert MTB\/RIF ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis. 2018;18(1):68\u201375.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"5004_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1473-3099(16)30067-6","volume":"16","author":"J Ho","year":"2016","unstructured":"Ho J, Nguyen PTB, Nguyen TA, Tran KH, Van Nguyen S, Nguyen NV, Nguyen HB, Luu KB, Fox GJ, Marks GB. Reassessment of the positive predictive value and specificity of Xpert MTB\/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis. Lancet Infect Dis. 2016;16(9):1045\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5004_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1378\/chest.09-2350","volume":"137","author":"R Diel","year":"2010","unstructured":"Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010;137(4):952\u201368.","journal-title":"Chest."},{"issue":"2","key":"5004_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1473-3099(18)30613-3","volume":"19","author":"HS Whitworth","year":"2019","unstructured":"Whitworth HS, Badhan A, Boakye AA, Takwoingi Y, Rees-Roberts M, Partlett C, Lambie H, Innes J, Cooke G, Lipman M, et al. Clinical utility of existing and second-generation interferon-\u03b3 release assays for diagnostic evaluation of tuberculosis: an observational cohort study. Lancet Infect Dis. 2019;19(2):193\u2013202.","journal-title":"Lancet Infect Dis"},{"key":"5004_CR12","unstructured":"World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update. WHO Guidelines Approved by the Guidelines Review Committee. 2013, Geneva: World Health Organization."},{"key":"5004_CR13","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Laboratory detection and identification of mycobacteria; approved guideline, CLSI document M48-A.Wayne: CLSI; 2008."},{"key":"5004_CR14","doi-asserted-by":"crossref","unstructured":"Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376\u201395.","DOI":"10.1164\/ajrccm.161.4.16141"},{"key":"5004_CR15","unstructured":"World Health Organization. The treatment of tuberculosis: guidelines. 4th ed. Available: https:\/\/www.who.int\/tb\/publications\/tb_treatmentguidelines\/en\/. Accessed 26 May 2018."},{"key":"5004_CR16","volume-title":"Diagnosis for pulmonary tuberculosis (WS 288\u20142017)","author":"National Health and Family Planning Commission of the People\u2019s Republic of China","year":"2017","unstructured":"National Health and Family Planning Commission of the People\u2019s Republic of China. Diagnosis for pulmonary tuberculosis (WS 288\u20142017). 2017; Available: http:\/\/www.nhc.gov.cn\/ewebeditor\/uploadfile\/2017\/11\/20171128164254246.pdf. Accessed 26 May 2018."},{"key":"5004_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12879-014-0709-7","volume":"14","author":"L Maynard-Smith","year":"2014","unstructured":"Maynard-Smith L, Larke N, Peters JA, Lawn SD. Diagnostic accuracy of the Xpert MTB\/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis. 2014;14:709.","journal-title":"BMC Infect Dis"},{"key":"5004_CR18","first-page":"CD009593","volume":"6","author":"DJ Horne","year":"2019","unstructured":"Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, Schumacher SG, Ochodo EA, Pai M, Steingart KR. Xpert MTB\/RIF and Xpert MTB\/RIF ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6:CD009593.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"5004_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/resp.13275","volume":"23","author":"DJ Christopher","year":"2018","unstructured":"Christopher DJ, Dinakaran S, Gupta R, James P, Isaac B, Thangakunam B. Thoracoscopic pleural biopsy improves yield of Xpert MTB\/RIF for diagnosis of pleural tuberculosis. Respirology. 2018;23(7):714\u20137.","journal-title":"Respirology."},{"issue":"1","key":"5004_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12879-018-3196-4","volume":"18","author":"ZY Huo","year":"2018","unstructured":"Huo ZY, Peng L. Is Xpert MTB\/RIF appropriate for diagnosing tuberculous pleurisy with pleural fluid samples? A systematic review. BMC Infect Dis. 2018;18(1):284.","journal-title":"BMC Infect Dis"},{"key":"5004_CR21","doi-asserted-by":"crossref","unstructured":"Theron G, Venter R, Smith L, Esmail A, Randall P, Sood V, Oelfese S, Calligaro G, Warren R, Dheda K. False-Positive Xpert MTB\/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes. J Clin Microbiol. 2018;56(3):e01696\u201317.","DOI":"10.1128\/JCM.01696-17"},{"issue":"3","key":"5004_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/0366-6999.223860","volume":"131","author":"WL Kang","year":"2018","unstructured":"Kang WL, Wang GR, Wu MY, Yang KY, Er-Tai A, Wu SC, Geng SJ, Li ZH, Li MW, Li L, et al. Interferon-gamma release assay is not appropriate for the diagnosis of active tuberculosis in high-burden tuberculosis settings: a retrospective multicenter investigation. Chin Med J. 2018;131(3):268\u201375.","journal-title":"Chin Med J"},{"issue":"1","key":"5004_CR23","first-page":"3","volume":"25","author":"National Technic Steering Group of the Epidemiological Sampling Survey for Tuberculosis","year":"2002","unstructured":"National Technic Steering Group of the Epidemiological Sampling Survey for Tuberculosis. Report on fourth national epidemiological sampling survey of tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 2002;25(1):3\u20137 in Chinese.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"4","key":"5004_CR24","first-page":"367","volume":"70","author":"L Pan","year":"2015","unstructured":"Pan L, Jia H, Liu F, Sun H, Gao M, Du F, Xing A, Du B, Sun Q, Wei R, et al. Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB. J Inf Secur. 2015;70(4):367\u201380.","journal-title":"J Inf Secur"},{"issue":"1","key":"5004_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/JCM.01463-09","volume":"48","author":"D Helb","year":"2010","unstructured":"Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229\u201337.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"5004_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.5588\/ijtld.16.0667","volume":"21","author":"ZX Zhang","year":"2017","unstructured":"Zhang ZX, Sng LH, Yong Y, Lin LM, Cheng TW, Seong NH, Yong FK. Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia. The International Journal of Tuberculosis and Lung Disease. 2017;21(5):544\u20139.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"5004_CR27","unstructured":"Technical Guidance Group of the Fifth National TB Epi-demiological Survey, the Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberculosis. 2012;34(8):485\u2013508 (in Chinese)."},{"key":"5004_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12866-016-0699-2","volume":"16","author":"Q-Q Yin","year":"2016","unstructured":"Yin Q-Q, Jiao W-W, Li Q-J, Xu F, Li J-Q, Sun L, Li Y-J, Huang H-R, Shen AD. Prevalence and molecular characteristics of drug-resistant mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. BMC Microbiol. 2016;16:85.","journal-title":"BMC Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05004-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05004-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05004-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T23:11:09Z","timestamp":1621811469000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05004-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5004"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05004-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"25 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of Peking University People\u2019s Hospital. Informed consent was not needed as this was a retrospective study and the medical records and patient information were anonymously reviewed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as no human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"362"}}